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Abstract
Background: The lack of epidemiologic information on osteoporotic hip fractures hampers the development of 
preventive or curative measures against osteoporosis in South Korea. We conducted a population-based study to 
estimate the annual incidence of hip fractures. Also, we examined factors associated with post-fracture mortality 
among Korean elderly to evaluate the impact of osteoporosis on our society and to identify high-risk populations.
Methods: The Korean National Health Insurance (NHI) claims database was used to identify the incidence of hip 
fractures, defined as patients having a claim record with a diagnosis of hip fracture and a hip fracture-related operation 
during 2003. The 6-month period prior to 2003 was set as a 'window period,' such that patients were defined as 
incident cases only if their first record of fracture was observed after the window period. Cox's proportional hazards 
model was used to investigate the relationship between survival time and baseline patient and provider characteristics 
available from the NHI data.
Results: The age-standardized annual incidence rate of hip fractures requiring operation over 50 years of age was 
146.38 per 100,000 women and 61.72 per 100,000 men, yielding a female to male ratio of 2.37. The 1-year mortality was 
16.55%, which is 2.85 times higher than the mortality rate for the general population (5.8%) in this age group. The risk 
of post-fracture mortality at one year is significantly higher for males and for persons having lower socioeconomic 
status, living in places other than the capital city, not taking anti-osteoporosis pharmacologic therapy following 
fracture, or receiving fracture-associated operations from more advanced hospitals such as general or tertiary hospitals.
Conclusion: This national epidemiological study will help raise awareness of osteoporotic hip fractures among the 
elderly population and hopefully motivate public health policy makers to develop effective national prevention 
strategies against osteoporosis to prevent hip fractures.
Background
Osteoporosis has become a significant public health
problem in recent years, especially with the growth of the
elderly population [1]. Hip fracture is the most valid epi-
demiologic marker of osteoporosis, a major cause of mor-
bidity and mortality in the aging population [1-3], and
imposes a considerable burden on patients, payers, and
society in terms of premature death, long-term disability,
restricted social functioning, cost of care, lost productiv-
ity, and informal caregiver time. Previous studies have
shown that the incidence rates of hip fractures for Asian
people were lower than those for Whites living in North-
ern Europe and North America [4-8]. However, recent
reports have shown an increase in the incidence of hip
fractures in Asian populations [4,9,10], and it is projected
that 45-70% of global hip fractures will occur in Asia by
2050 due to the growth of the elderly population [1,11].
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Page 2 of 9To reduce the cost of fracture care, it is important to
adopt effective prevention strategies to reduce osteopo-
rosis, including dietary supplements such as calcium and
vitamin D and pharmacologic therapy. However, the lack
of detailed data on hip fracture epidemiology, particularly
in developing countries, hampers the development of
preventive or curative measures against osteoporosis
[12]. Thus, knowledge regarding the incidence of hip
fractures and their outcomes, including mortality, is
needed to evaluate the impact of osteoporosis on our
society, to identify high-risk populations, and to help
health care decision-makers allocate scarce resources and
prioritize hip fractures along with other important clini-
cal problems.
While the growth of the elderly population (>65 years
of age) in South Korea has been as marked as in other
Asian countries, rising from 3.8% in 1980 to 7.9% in 2002
[13], epidemiologic information about hip fractures
among the elderly in South Korea is scarce. To provide a
national estimate on the incidence rate of hip fractures in
this population, we need a result derived from a large,
population-based database for Korea. The Korean
National Health Insurance (NHI) claims database is such
a database, containing all medical and prescription drug-
claim records for almost 100% of the Korean population.
South Korea operates a mandatory universal health
insurance system, with a centralized healthcare claims
database that provides a unique nationwide source of
information on health care resource utilization. We used
this database to estimate the annual incidence and 1-year
mortality of hip fractures in Koreans over the age of 50.
Furthermore, we assessed the patient and provider char-
acteristics associated with post-fracture mortality in
order to help identify high-risk patients with poor health
outcomes and develop effective treatment strategies after
hip fracture incidence. The study results are expected to
increase our understanding of the magnitude of the
elderly population suffering from hip fractures and to
urge public health policy makers to develop effective
national prevention strategies for osteoporosis.
Methods
Data sources and study population
Records from the Korean NHI claims database from 2002
and 2004 were used to identify patients with hip fractures
and to monitor their 1-year mortality. The incidence of
hip fractures was defined as patients having a claim
record with a diagnosis of hip fracture and a hip fracture-
related operation. Since identifying hip fracture cases
solely based on diagnosis is likely to cause misclassifica-
tion problems due to potential miscoding, we combined
the information from both diagnosis and surgical records.
This conservative approach underestimates the real inci-
dence rate of hip fractures in Korea, but improves the
validity of the incidence cases identified from insurance
claims data.
All claims records of outpatient visits or hospital
admissions of patients aged 50 or older containing a diag-
nosis of femur fracture (fracture of femur [International
Classification of Diseases (ICD)-10 diagnostic code: S72],
fracture of the neck of the femur [S72.0, S72.00], pertro-
chanteric fracture [S72.1, S72.10]) and hip fracture-
related operation (open reduction & internal fixation
[ICD-10 procedure code: N0601], closed reduction and
percutaneous fixation [N0991], total hip replacement
[N0711], or hip hemiarthroplasty [N0715]) from January
1 to December 31, 2003 were identified from the NHI
claims database. The diagnosis and operation code for
hip fracture was selected based on previous epidemio-
logic studies [1,14] and was confirmed by a panel of four
orthopedic clinicians working in four different general
hospitals in Korea. The cases having more than one claim
record that satisfied the inclusion criteria during 2003
were counted only once.
In general, not all operations are carried out during the
first fracture visit or admission. However, most of the
operations are performed within a month following the
first visit, according to a consultation of orthopedic clini-
cians in Korea. Thus, we additionally defined the inci-
dence cases as patients who did not have a record of a hip
fracture-related operation in the claim record of the ini-
tial visit or admission, but had it within a month after the
initial visit.
The 6-month period prior to 2003 (i.e., July - Decem-
ber, 2002) was set as a 'window period,' such that patients
were defined as incident cases only if their first record of
a fracture visit or admission was observed after this 6-
month period. Since most of the follow-up treatments for
hip fracture are completed within 6 months after the ini-
tial fracture, we assumed that the absence of any claims
record with a diagnosis of hip fracture and hip-fracture-
related operation in the previous 6 months assured that
the fracture was a new case.
NHI claims data were merged with national mortality
data provided by the National Statistical Office to deter-
mine the survival status of individual patients at the 12
months following the incidence.
Data analysis
Age- and sex-specific annual incidence rates of hip frac-
tures per 100,000 inhabitants were calculated and pre-
sented in 5-year age intervals. The number of inhabitants
in South Korea, as of 2003, was obtained from the Korean
National Statistical Office. The age-standardized inci-
dence rate was computed using the Korea Census data of
2000. Age- and sex-specific 1-year mortality rates of hip
fractures were calculated and presented in 5-year age
intervals. To examine the difference in the incidence and
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ratio of incidence and 1-year mortality rate was com-
puted for each 5-year age stratum.
Cox's proportional hazards model was used to investi-
gate the relationship between survival time and baseline
patient and provider characteristics. The independent
variables were age, gender, type of fracture, type of opera-
tion, baseline health status, residence area, type of health
insurance, provision of anti-osteoporosis medication
therapy after fracture, and type of hospital providing
operation.
Results
During the 1-year observation period from January
through December 2003, there were 9,817 incidents of
hip fractures in persons aged 50 and older in South
Korea: 6,892 females (70.2%) and 2,925 males (29.8%).
The mean (± SD) and the median age were 74.92 (± 9.13)
and 76 years old, respectively. The mean age was younger
in men (72.10 ± 9.47 years) than in women (76.11 ± 8.72
years). The age-standardized annual incidence rate of hip
fractures was 104.06 per 100,000; 146.38 per 100,000
women and 61.72 per 100,000 men, yielding a female/
male ratio of 2.37 (Table 1).
The incidence rate of hip fractures increased with
increasing age, from 6.74 per 100,000 for the youngest
group of 50-54 year olds to 686.82 per 100,000 for the
oldest group of 85 years and older. This increase followed
an exponential relationship after age 65 for both genders
(Figure 1). About 34.0% of all hip fractures occurred in
patients aged 80 years and older, although this age group
comprised only 5.6% of the total population over 50.
The gender ratio of the female to male incidence rate
was computed for the 5-year age stratum. The ratio for
the youngest 5-year group (50-54 years old) was smaller
than 1, indicating a higher incidence rate among males
than among females, probably due to occupation. How-
ever, this ratio increased with increasing age and was
greater than 1 for all groups older than or equal to 55
years old.
Of 9,817 patients, 1,625 died during the first year post-
fracture, yielding a mortality rate of 16.55% (Table 2). The
mortality rate increased with increasing age from less
than 10% of patients aged younger than 65 to more than
20% of those over 80 years old. Male patients consistently
showed a higher mortality rate than female patients in all
age categories except the youngest, with the ratio of
female to male mortality ranging from 0.48 to 0.72, com-
pared with 3.77 in the youngest group.
Patient and provider characteristics available from the
NHI claims data were examined for their association with
1-year post-fracture mortality using the multivariate
Cox-proportional hazard model (Table 3). While other
factors were held constant in the multivariate model, gen-
der and age remained statistically significant factors
affecting patient survival after hip fracture. As compared
to the patients residing in Seoul, the capital city of South
Korea, those living in other parts of South Korea had a
significantly higher risk of death following fracture,
which showed a hazard ratio ranging from 1.291 (95%
confidence interval (CI): 1.120-1.488) for those in metro-
politan cities to 1.656 (95% CI: 1.344-2.039) for those in
non-city areas.
To examine the impact of socioeconomic status on the
mortality of hip fractures, we compared the mortality
between elderly enrolled in the two tiers of the Korean
universal health insurance system: the Health Insurance
(HI) and the Medical Aid (MA) program. The HI is a
wage-based, contributory insurance program covering
about 97% of the population, whereas the MA is a gov-
ernment-subsidized, public assistance program for the
poor and the medically indigent. The NHI claims data
include records for both the HI and the MA program
populations. The survival analysis showed that patients
enrolled in the MA program had a 30% higher chance of
death during the year following fracture than those in the
HI program (hazard ratio: 1.300, 95% CI: 1.136-1.488).
As a proxy measure for patients' baseline health status,
a Charlson comorbidity index [15] was assigned to each
study subject based on the diagnosis shown in the NHI
claims record during the study period prior to hip frac-
ture. Charlson et al. developed a scoring system for
comorbid illness, such that each comorbid condition was
assigned a whole number integer ranging from 1 to 6,
which was proportional to the relative risk of 1-year mor-
tality associated with that disease [16]. Not surprisingly,
those who had had severe comorbid conditions before
they had the fracture outbreak were 1.339 (for those with
Charlson Index of 1), 2.625 (Index of 2), or 5.693 (Index of
3 or 6) times more likely to die as compared to those
without any of the Charlson Index conditions.
The risk of mortality following fracture was not signifi-
cantly different according to the type of hip fracture or
operation. The likelihood of dying among those with
claims records showing at least one reimbursed prescrip-
tion for anti-osteoporosis drugs (alendronate, etidronate,
raloxifen, risedronate, and salcatonin) following hip frac-
ture was 42.4% lower than those without such claims
records.
As the level and the size of the hospital in which the
patients received their operation decreased, so did the
chance of death. The hazard ratios of 1-year mortality,
with tertiary hospitals as a reference group, were 0.798
(95% CI: 0.680-0.937) for hospitals and 0.746 for clinics
(95% CI: 0.573-0.972).
Discussion
This is the first nation-wide, population-based, epidemi-
ologic study of hip fractures in Korea and one of the few
studies worldwide reporting the incidence of hip frac-
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age-standardized annual incidence rate for the entire
population of Korea over 50 years of age in 2003 was esti-
mated as 104.06 per 100,000 inhabitants, which is about
27.8% lower than that estimated in an earlier study con-
ducted on inhabitants residing in selected regions of
Korea in 2001 (133 per 100,000) [17]. The difference in
the estimated incidence rates between the two studies
can be explained by the difference in the dataset, meth-
ods used in each study to identify incidence cases, and
the population characteristics in the study regions. In the
earlier study, hip fracture cases admitted to selected hos-
pitals in Gwangju City and Chonnam Province were iden-
tified on the basis of medical records and radiographs.
Among the identified incidence cases in that study, 88%
underwent surgery. By applying this operation rate to the
incidence rate estimated by our study, the total number of
incidence cases with and without operation was esti-
mated as 118.3 per 100,000 (= 104.6/0.88), thereby reduc-
ing the gap in the incidence estimates between the two
studies from 27.8% to 12.4%.
After standardization according to the age distribution
of the US white population in 1990 [18], the incidence
rates of hip fractures in Korea were 173 per 100,000 in
women and 91 per 100,000 in men. Interestingly, the
standardized incidence rates of both genders were sub-
stantially lower than those of most of the Asian countries
including Taiwan (505 per 100,000 in women and 225 per
100,000 in men), Hong Kong (459 and 180 per 100,000),
Singapore (442 and 164 per 100,000), and Thailand (269
and 114 per 100,000) [9].
The risk of 1-year mortality following hip fracture was
16.55%, which is about 2.85 times higher than the mortal-
ity rate of the general population in South Korea over 50
years of age. Despite the heterogeneity of the study popu-
lation in terms of age and ethnicity, and the potential dis-
crepancy in the quality of follow-up care after the
fracture, the post-fracture mortality at 1 year observed in
other countries is similar to that in Korea. A recent U.S.
study has reported that about 11.5% of 950 patients over
age 65 admitted to selected hospitals with a hip fracture
between 1987 and 1997 died after 1 year [19]. The 1-year
mortality rate was 15.7% among 541 fracture patients
over 60 years of age admitted to one university hospital in
Greece between 1989 and 1992 [20]. In a population-
based, case-control study in Sweden, about 10.6% of
2,245 women aged 50-81 years admitted with a hip frac-
ture died within 1 year [21]. The comparison with other
Asian countries also showed similar results. The 1-year
mortality of patients with surgically treated hip fractures
at a hospital in Taiwan between 1998 and 2006 was about
14.0% [22]. A Japanese study by Muraki et al. reported
that the 1-year mortality rate following hip fracture was
11.5% [23].
Osteoporosis is recognized as a problem predominantly
in elderly women [24,25]. Consequently, women have
higher incidence rates of hip fracture than men. In Korea,
the female to male ratio of the age-standardized inci-
Table 1: Sex- and age-specific annual incidence rates of hip fractures in South Korea in 2003
Total Female Male
Age
(years)
No. 
population 
2003
No. hip fx. Incidence 
per 
100,000
No. popl 
2003
No. hip fx. Incid. Per 
100,000
No. popl 
2003
No. hip fx. Incid. Per 
100,000
F/M  ratio 
 of  incid.
50-54 2,567,149 173 6.74 1,274,375 69 5.41 1,292,774 104 8.04 0.67
55-59 2,104,791 403 19.15 1,061,917 205 19.30 1,042,874 198 18.99 1.02
60-64 1,935,661 824 42.57 1,023,028 449 43.89 912,633 375 41.09 1.07
65-69 1,594,318 1,311 82.23 882,721 817 92.55 711,597 494 69.42 1.33
70-74 1,099,247 1,790 162.84 665,698 1,245 187.02 433,549 545 125.71 1.49
75-79 683,904 1,982 289.81 441,732 1470 332.78 242,172 512 211.42 1.57
80-84 380,112 1,888 496.70 259,291 1456 561.53 120,821 432 357.55 1.57
85+ 210,537 1,446 686.82 159,330 1181 741.23 51,207 265 517.51 1.43
Overall 
(50+)
10,575,719 9,817 92.83 5,768,092 6,892 119.48 4,807,627 2,925 60.84 1.96
Age-standardized rates* 104.06 146.38 61.72 2.37
*Age-standardized incidence rate was computed using Korea Census data of 2000.
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2.37. This ratio is comparable to western countries such
as Sweden (2.2, 1987-1991), Norway (2.3, 1983-1984),
Australia (2.7, 1989-1990), and in U.S. whites (2.7, 1983-
1984), and in some Asian countries such as Thailand (2.3,
1997-1998), Hong Kong (2.5, 1997-1998), and Malaysia
(2.4, 1997-1998) [3]. Hip fracture rates were higher in
women of all age groups except for those under 55 years.
This pattern is commonly observed in populations of
other countries, although the starting age at which
women show a higher hip fracture rate varies from coun-
try to county: 60 in Taiwan and Japan [4,9], but mostly 55
or 50 in other countries such as Mexico, Argentina, Iran,
and Morocco [1-3,5].
Although women showed consistently higher incidence
rates of hip fractures than men, the high incidence rates
among older men is worthy of attention. After age 75,
Korean men experienced hip fractures at a rate of 211.42
to 517.51 per 100,000 inhabitants. This rate is similar to
that observed in other Asian countries, such as Japan
(209.0 to 780 per 100,000), Hong Kong (404 to 1,639),
Singapore (611), Malaysia (320), and Thailand (227 to
727) [4,6]. The increased incidence with increasing age in
both genders confirms the equal vulnerability of both
genders to the aging process. Thus, preventive strategies
are important for both genders.
It is interesting to observe higher post-fracture mortal-
ity in Korean males than in females. Gender differences
in post-hip fracture mortality have been reported in ear-
lier studies showing that men were about twice as likely
as women to die during the first years after hip fracture
[26-28]. The observed difference between men and
women could be explained by under treatment of osteo-
porosis [28] and higher infection rates in men following
hip fracture [26,27].
Low socioeconomic status among the elderly popula-
tion seems to be associated with an increased risk of frac-
ture-caused mortality. The adjusted hazard ratio of post-
fracture mortality was significantly higher among those
enrolled in the MA program than among those in the HI
program. Patients with low socioeconomic status, in gen-
eral, have poorer health status and therefore tend to have
poorer health outcomes from the same conditions as
compared to those with higher socioeconomic status
[29,30]. Thus, more effective public health strategies to
treat osteoporosis and to prevent fracture incidence
should be implemented that target the indigent elderly
population in Korea.
The regional variation in fracture-related mortality
among Korean elderly is noteworthy. Those living in
places other than the capital city consistently showed a
higher risk of death during the first year after hip fracture,
with a minimum of 21.4% or a maximum of 65.6% addi-
Figure 1 Comparison of age-specific incidence rates of hip frac-
ture according to gender.
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Table 2: Sex- and age-specific post-hip fracture mortality rate at 1 year
Total Female Male
Age
(years)
No. hip
Fx. 2003
No.
mortality
Mortality
rate (%)
No. hip
Fx. 2003
No.
mortality
Mortality
rate (%)
No. hip
Fx. 2003
No.
mortality
Mortality 
rate (%)
F/M ratio of 
mortality rate
50-54 173 14 8.09 69 10 14.49 104 4 3.85 3.77
55-59 403 21 5.21 205 7 3.41 198 14 7.07 0.48
60-64 824 76 9.22 449 32 7.13 375 44 11.73 0.61
65-69 1,311 150 11.44 817 78 9.55 494 72 14.57 0.66
70-74 1,790 216 12.07 1,245 125 10.04 545 91 16.70 0.60
75-79 1,982 347 17.51 1470 224 15.24 512 123 24.02 0.63
80-84 1,888 413 21.88 1456 293 20.12 432 120 27.78 0.72
85+ 1,446 388 26.83 1181 296 25.06 265 92 34.72 0.72
Overall 
(50+)
9,817 1,625 16.55 6,892 1,065 15.45 2,925 560 19.15 0.81
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Table 3: Multivariate survival analysis: Patient and provider characteristics associated with 1-year mortality after hip 
fracture
Variables N (%) Hazard ratio 95% confidence interval
Gender Female 6,892 (70.2) 1.000
Male 2,925 (29.8) 1.400 (1.260-1.557)
Age (years) 50-59 576 (5.9) 1.000
60-69 2,135 (21.7) 1.787 (1.250-2.553)
70-79 3,772 (38.4) 2.879 (2.041-4.062)
80-89 2,923 (29.8) 4.742 (3.361-6.691)
≥ 90 411 (4.2) 9.273 (6.387-13.463)
Residence Seoul (Capital city) 2,388 (24.3) 1.000
Metropolitan city 2,584 (26.3) 1.291 (1.120-1.488)
Small city 4,133 (42.1) 1.214 (1.058-1.392)
Others (none-city area) 712 (7.3) 1.656 (1.344-2.039)
Health
insurance
National Health Insurance program 8,514 (86.7) 1.000
National Medical Aid program 1,303 (13.3) 1.300 (1.136-1.488)
Baseline 0 4,742 (48.3) 1.000
Charlson 1 4,038 (41.1) 1.339 (1.198-1.496)
Index (before hip 
fracture)
2 938 (9.6) 2.625 (2.264-3.042)
3, 6 99 (1.0) 5.693 (4.249-7.627)
Type of
hip fracture
Neck fracture 5,435 (55.4) 1.000
Petrochanteric fracture. 3,733 (38.0) 1.090 (0.966-1.230)
Neck + Petrochanteric fracture. 649 (6.6) 1.031 (0.843-1.261)
Type of operation Total hip replacement (ICD 10th 
procedure code: N0711)
4,574 (46.6) 1.000
Open reduction/internal fixation 
(N0601)
4,592 (46.8) 0.963 (0.855-1.084)
Closed reduction/percutaneous 
fixation (N0991)
397 (4.0) 0.958 (0.720-1.274)
Hip hemiarthroplasty (N0715) 216 (2.2) 0.793 (0.536-1.174)
Total hip replacement & Open 
reduction (N0711 + N0601)
38 (0.4) 1.213 (0.575-2.561)
Treatment* No 7,761 (79.1) 1.000
Yes 2,056 (20.9) 0.576 (0.499-0.666)
Type of hospital providing 
operation
Tertiary hospital 2,714 (27.6) 1.000
General hospital 4,649 (47.4) 0.900 (0.796-1.018)
Hospital 1,901 (19.4) 0.798 (0.680-0.937)
Clinic 553 (5.6) 0.746 (0.573-0.972)
* Treatment was defined as whether the patient took at least one prescription of anti-osteoporosis medicine after hip fracture.
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the lack of access to health care providers or the poor
quality of health care provided in non-city or small city
areas. Further investigation is necessary to figure out the
reasons for this regional discrepancy and therefore to
reduce this discrepancy.
From our analysis, patients receiving medication to
treat osteoporosis after fracture were 42.4% less likely to
die within the year following fracture. The association
between reduced mortality and post-fracture use of anti-
osteoporosis drugs in elderly hip fracture patients has
been addressed in earlier studies. A prospective analysis
from Finland has reported a 43% reduction in deaths at
36 months following hip fracture in females who used
prescribed calcium plus vitamin D supplementation con-
comitantly with anti-osteoporosis drugs [31]. Also, an
observational study from Canada has shown that mortal-
ity is significantly lower in the group treated with anti-
osteoporosis drugs than in the untreated group following
hip fracture [32]. Because elderly people with prior frac-
tures are at a higher risk for future fractures [33], clinical
practice guidelines recommend the initiation of pharma-
cologic treatment of osteoporosis after the first fracture
[34]. However, under-treatment of osteoporosis [35,36]
and low adherence to oral anti-osteoporosis treatment
following hip fracture [37] is commonly observed. In our
study, only 20.9% of the fractured patients received anti-
osteoporosis drugs following hip fracture. Thus, a more
aggressive practice of diagnosing and providing medica-
tion therapy for osteoporosis seems to be an urgent need
in Korea.
Interestingly, patients that underwent an operation for
hip fracture from hospitals or clinics tend to have a better
chance of survival than those from tertiary hospitals.
Although our multivariate model tried to include as many
patient characteristic variables as possible from the NHI
data, we could not comprehensively control for hip frac-
ture severity and patient health conditions due to the lack
of clinical information available from the claims records.
Thus, it cannot be concluded that the quality of care and
patient outcomes after hip fracture treatment are better
among hospitals and clinics than among tertiary hospitals
in Korea. It might be possible that patients with more
severe conditions underwent hip fracture repairs from
larger and more advanced hospitals (i.e., tertiary or gen-
eral hospitals) and therefore the prognosis after surgery
tended to be poorer. A more thorough adjustment for
patient baseline disease severity is necessary to make a
concrete conclusion about this finding.
Since a hip fracture is a severe condition, most of the
care episodes are initiated with hospital admission and
most prior studies have relied on hospitalized hip frac-
tures to identify incident cases [14,17]. However, if we
restrict the study sample to include hospitalized fractures
only, we will underestimate incidence rates by excluding
less severe cases that are initiated with office visits. To
overcome this problem, the present study defined inci-
dent cases either by initial admission or a visit containing
a diagnosis of hip fracture. However, while most hospital
admissions coincide with an acute new episode of illness,
it is difficult for outpatient visits to determine whether
the case is a new episode or part of a post-episode course.
In addition, the accuracy of diagnostic codes among the
claims data for office visits is lower than that of hospital
admission [38,39]. Thus, to improve the accuracy of iden-
tifying incidence cases based on initial fracture visits, we
excluded patients with a claims record with a hip fracture
during the 6 months prior to the initial visit. Further-
more, to confirm the hip fracture cases, hip fracture-
related operation codes were used in addition to the diag-
nostic codes.
Several methodological issues arise from the studies
using administrative claims data. First, not all patients
with fractures have access to hospitals. The incidence
based on insurance claims records would be underesti-
mated if many hip fractures in Korea were not diagnosed
or treated in health care institutions. However, due to the
emergent character of hip fractures, it is believed that vir-
tually all hip fractures present to health services [3].
Thus, the incidence of hip fractures identified from
claims records is considered to be close to the actual inci-
dence.
Second, the reliance on ICD-10 diagnostic codes to
identify incident fractures may cause misclassification of
incident hip fractures due to the inherent nature of claims
data such as voluntary or non-voluntary miscoding
behavior. However, a recent validation study for the diag-
nostic codes of the NHI claims database in Korea has alle-
viated this concern. It has been revealed that about 70%
of primary, secondary, or tertiary diagnosis codes from
NHI claims records coincide with those from medical
records. In addition, the accuracy of diagnosis codes
tended to be higher for claims from hospital admissions
compared with office visits, and for claims of severe con-
ditions compared with mild conditions [38,39].
Conclusion
In conclusion, our results indicate a high incidence and
mortality rate of hip fractures for both men and women
living in South Korea. These high incidence rates for both
genders are sentinel signals of the impact of hip fractures
in Korea, in terms of high mortality, morbidity, and
health care costs for treatment. It is our hope that this
national epidemiological study will help raise the aware-
ness of hip fractures among the elderly population and
support the practice of aggressive diagnosis and the
adoption of effective treatment options for osteoporosis.
Kang et al. BMC Public Health 2010, 10:230
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